Related Experiment Video
Updated: Mar 1, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Genomic medicine and targeted therapy for solid tumors
Emily A Stevens1, Cristina P Rodriguez
1Seattle Cancer Care Alliance, University of Washington, Seattle, Washington; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
Cancer treatment has shifted from general chemotherapy to targeted therapies by understanding tumor growth mechanisms. This review highlights advances in targeted cancer therapy for epithelial cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Cancer therapy has significantly evolved over the last two decades.
- Treatment has transitioned from non-specific cytotoxic chemotherapy to targeted therapies.
- This shift targets specific molecular pathways driving cancer growth.
Purpose of the Study:
- To review major clinical advances in targeted cancer therapy.
- Focus on select epithelial malignancies.
- Emphasize the role of genomic understanding in driving these advances.
Main Methods:
- Review of clinical advances in targeted cancer therapy.
- Focus on molecular mechanisms and genomic insights.
- Analysis of treatment approaches in metastatic and adjuvant settings.
Main Results:
- Significant progress in targeted therapies for epithelial cancers.
- Genomic understanding has enabled personalized treatment strategies.
- Improved outcomes in metastatic and adjuvant cancer treatment.
Conclusions:
- Targeted cancer therapy, driven by genomic insights, represents a paradigm shift.
- Understanding molecular mechanisms is crucial for developing effective cancer treatments.
- Continued research in genomics will further advance epithelial malignancy therapies.
More Related Videos
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy